Investment company 5AM Venture Management, LLC (Current Portfolio) buys Pear Therapeutics Inc, Entrada Therapeutics Inc, sells Crinetics Pharmaceuticals Inc, Avidity Biosciences Inc, Silverback ...
The Pear Therapeutics, Inc. (NASDAQ:PEAR) share price has fared very poorly over the last month, falling by a substantial 82%. For any long-term shareholders, the last month ends a year to forget by ...
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines in the United States. Its commercial products are reSET for the treatment of substance use ...
A downtrend has been apparent in Pear Therapeutics, Inc. (PEAR) lately with too much selling pressure. The stock has declined 17.4% over the past four weeks. However, given the fact that it is now in ...
BOSTON--(BUSINESS WIRE)--Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), today announced ...
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced results from a ...
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), rings the Nasdaq Closing Bell remotely ...
Good afternoon, everyone. Welcome to the Pear Therapeutics Third Quarter 2022 Earnings Conference Call. My name is Elizabeth, and I will be your operator today. [Operator Instructions] This call is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback